JP2023513350A5 - - Google Patents
Info
- Publication number
- JP2023513350A5 JP2023513350A5 JP2022548836A JP2022548836A JP2023513350A5 JP 2023513350 A5 JP2023513350 A5 JP 2023513350A5 JP 2022548836 A JP2022548836 A JP 2022548836A JP 2022548836 A JP2022548836 A JP 2022548836A JP 2023513350 A5 JP2023513350 A5 JP 2023513350A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- cancer
- seq
- modified immune
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062976493P | 2020-02-14 | 2020-02-14 | |
| US62/976,493 | 2020-02-14 | ||
| PCT/GB2021/050341 WO2021161032A1 (en) | 2020-02-14 | 2021-02-12 | Method of treatment of cancer or tumour |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513350A JP2023513350A (ja) | 2023-03-30 |
| JP2023513350A5 true JP2023513350A5 (https=) | 2024-02-21 |
Family
ID=74759208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548836A Pending JP2023513350A (ja) | 2020-02-14 | 2021-02-12 | がんまたは腫瘍の治療の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230390334A1 (https=) |
| EP (1) | EP4103284A1 (https=) |
| JP (1) | JP2023513350A (https=) |
| CN (1) | CN115087489A (https=) |
| AU (1) | AU2021219334A1 (https=) |
| CA (1) | CA3167436A1 (https=) |
| WO (1) | WO2021161032A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2501870C (en) | 2002-10-09 | 2013-07-02 | Avidex Limited | Single chain recombinant t cell receptors |
| ATE475669T1 (de) | 2004-06-29 | 2010-08-15 | Immunocore Ltd | Einen modifizierten t-zellen-rezeptor exprimierende zellen |
| GB201313377D0 (en) * | 2013-07-26 | 2013-09-11 | Adaptimmune Ltd | T cell receptors |
| JP7037577B2 (ja) * | 2017-03-15 | 2022-03-16 | フレッド ハッチンソン キャンサー リサーチ センター | 高親和性ｍａｇｅ－ａ１特異的ｔｃｒ及びその使用 |
| CN110776562B (zh) * | 2018-07-30 | 2022-06-17 | 香雪生命科学技术（广东）有限公司 | 一种识别afp抗原的t细胞受体 |
-
2021
- 2021-02-12 EP EP21708300.5A patent/EP4103284A1/en not_active Withdrawn
- 2021-02-12 AU AU2021219334A patent/AU2021219334A1/en active Pending
- 2021-02-12 CA CA3167436A patent/CA3167436A1/en active Pending
- 2021-02-12 CN CN202180014540.3A patent/CN115087489A/zh active Pending
- 2021-02-12 JP JP2022548836A patent/JP2023513350A/ja active Pending
- 2021-02-12 WO PCT/GB2021/050341 patent/WO2021161032A1/en not_active Ceased
- 2021-02-12 US US17/819,480 patent/US20230390334A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kwa et al. | Checkpoint inhibitors in triple‐negative breast cancer (TNBC): Where to go from here | |
| Kudo | Immuno-oncology therapy for hepatocellular carcinoma: current status and ongoing trials | |
| Ventola | Cancer immunotherapy, part 2: efficacy, safety, and other clinical considerations | |
| TWI786044B (zh) | 藉由投予ｐｄ-１抑制劑治療皮膚癌之方法 | |
| Ye et al. | Clinical immunotherapy in pancreatic cancer | |
| JP2022078265A (ja) | 肺癌の処置のための抗ｐｄ－１抗体 | |
| JP2023526259A5 (https=) | ||
| JP2025065211A (ja) | 癌の治療における有効性の増強のためのｐｄ－１阻害剤とｌａｇ－３阻害剤の組み合わせ | |
| JP2023528206A5 (https=) | ||
| Floudas et al. | Immunotherapy: current status and future perspectives | |
| IL304945A (en) | Methods for treating cancer by administering a PD-1 inhibitor as adjuvant therapy | |
| JP2023011902A (ja) | Ｐｄ－１阻害剤を投与することにより子宮頸がんを処置する方法 | |
| JP7523907B2 (ja) | 非成人のヒトに対する抗ｃｄ３０抗体－薬物コンジュゲートの投与 | |
| JP2023513350A5 (https=) | ||
| KR20250155054A (ko) | 흑색종 치료에서의 효능 강화를 위한 pd-1 억제제와 lag-3 억제제의 병용 | |
| Al-Hadidi et al. | Programmed cell death-one inhibition therapy in classical Hodgkin lymphoma | |
| Ascierto et al. | Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”(December 4th–5th, 2019, Naples, Italy) | |
| EP4638503A1 (en) | Combination therapy for lung cancer | |
| AU2021332246A1 (en) | Methods of treating cancer by administering a pd-1 inhibitor | |
| Badiyan et al. | Immunotherapy and radiation therapy for gastrointestinal malignancies: hope or hype? | |
| RU2833461C1 (ru) | Способы лечения рака шейки матки путем введения инибитора pd-1 | |
| RU2842292C1 (ru) | Способы лечения рака посредством введения ингибитора pd-1 | |
| White et al. | Cancer immunotherapy | |
| Esagian et al. | Immunotherapy for the Treatment of Hepatocellular Carcinoma | |
| Nathael et al. | Immunotherapy in Triple Negative Breast Cancer: Approved and in Development Anti PD-(L) 1 |